ScreenerHero

SGP SpyGlass Pharma, Inc.

NAS · US · Healthcare · Biotechnology · spyglasspharma.com
23.90USD-3.55%Mkt Cap: 799.41M $P/E: —

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL S…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap799.41M USD
Enterprise Value596.29M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-39.87M USD
Revenue/Share—
Last Price23.90 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.22
PEG—
EV/EBITDA-9.76
EV/Revenue—
P/S—
P/B3.57
EPS (TTM)-2.43
EPS (Forward)-2.69
52W Range
17.0644% of range32.44
52W High32.44 USD
52W Low17.06 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE40.34%
ROA-34.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-32.70M USD
CapEx (TTM)789.00K USD
FCF Margin—
FCF Yield—
Net Debt-232.55M USD
Net Debt/EBITDA3.81
Balance Sheet
Debt/Equity-0.02
Current Ratio25.06
Quick Ratio24.89
Book Value/Sh6.95 USD
Cash/Share7.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)44.00 USD
Upside (mean)+84.1%
Target Range37.00 USD – 62.00 USD
37.00+84.1% to mean62.00
# Analysts6
Ownership
Shares Out.33.45M
Float6.50M
Insiders4.28%
Institutions94.69%
Short Interest
Short Ratio13.9d
Short % Float11.07%
Short % Out.3.68%
Shares Short1.23M
Short (prev mo.)1.14M
Technical
SMA 5026.20 (-8.8%)
SMA 20024.06 (-0.7%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)130.57K
Avg Vol (10d)114.26K
Technical Indicators
RSI (14)35.9
MACD-0.5171
MACD Signal-0.0135
MACD Hist.-0.5036
BB Upper30.36 USD
BB Middle27.11 USD
BB Lower23.85 USD
BB Width23.98%
ATR (14)1.485 USD
Vol Ratio (20d)0.45x